Phebra gains DigFab

 In Australia, NewZealand, Pharmacy

PHEBRA has signed an exclusive distribution agreement with Protherics Medicines Development to distribute DigiFab (digoxin immune fab (ovine) ), an antidote for the treatment of patients suffering life- threatening digoxin toxicity, in Australia and NZ. Pharmacy Daily – Read More.


Recent Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.